200-066-2

Applied Filters:

Keyword:'200-066-2'

Showing 1-1 of 1 result for "200-066-2" within Papers

Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066).

Craig W Hendrix et al.

AIDS research and human retroviruses, 32(1), 32-43 (2015-09-29)

Oral preexposure prophylaxis (PrEP) trials report disparate efficacy attributed to variable adherence. HPTN 066 was conducted to establish objective, quantitative benchmarks for discrete, regular levels of adherence using directly observed dosing of tenofovir (TFV) disoproxil fumarate (TDF)/emtricitabine (FTC). Healthy, HIV-uninfected

Page 1 of 1